Krisp, Christoph
Parker, Robert
Pascovici, Dana
Hayward, Nicholas K.
Wilmott, James S.
Thompson, John F.
Mann, Graham J.
Long, Georgina V.
Scolyer, Richard A.
Molloy, Mark P. http://orcid.org/0000-0003-4679-5868
Article History
Received: 10 April 2018
Revised: 17 July 2018
Accepted: 19 July 2018
First Online: 17 August 2018
Ethics approval and consent to participate
: The fresh-frozen melanoma tumor samples were obtained from the Melanoma Institute Australia Biospecimen Bank, accrued with written informed patient consent and approved by Institutional Review Board (Sydney South West Area Health Service institutional ethics review committee (Royal Prince Alfred Hospital (RPAH) Zone) Protocol No. X08-0155/HREC 08/RPAH/262, No. X11-0023/HREC 11/RPAH/32, and No. X07-0202/HREC/07/RPAH/30). This study was performed in accordance with the principles of the Declaration of Helsinki.
: The authors declare no competing interests.
: The mass spectrometry proteomics data have been deposited to the ProteomeXchange ConsortiumSuperscript removed via the PRIDE partner repository with the dataset identifier PXD002725 for in-vitro study and PXD007083 for human tissue specimen study.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).